Teladoc Health had its Relative Strength (RS) Rating upgraded from 69 to 75 Monday — a welcome improvement, but still below the 80 or higher score you prefer to see.
IBD's proprietary rating identifies share price action with a 1 (worst) to 99 (best) score. The rating shows how a stock's price performance over the trailing 52 weeks compares to all the other stocks in our database.
Over 100 years of market history shows that the best-performing stocks typically have an 80 or better RS Rating as they launch their biggest price moves. See if Teladoc Health can continue to rebound and clear that threshold.
Can You Really Time The Stock Market?
While the stock is not near a proper buy zone right now, see if it manages to form and break out from a proper chart pattern.
The company reported negative growth for both sales and earnings last quarter.
The company holds the No. 9 rank among its peers in the Computer Software-Medical industry group. Doximity, Veeva Systems Cl A and Waystar Holding are among the top 5 highly rated stocks within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
